QuidelOrtho (QDEL) Depreciation & Amortization (CF) (2021 - 2026)
QuidelOrtho (QDEL) posted Depreciation & Amortization (CF) of $112.9 million for Q1 2026, little changed sequentially from $112.5 million in Q4 2025, and up 5.42% YoY from $107.1 million in Q1 2025.
QuidelOrtho (QDEL) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends
QuidelOrtho has reported Depreciation & Amortization (CF) for 6 years, with the latest figure at $112.9 million in Q1 2026.
- Quarterly Depreciation & Amortization (CF) rose 5.42% year-over-year to $112.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $447.8 million (changed 0.49% YoY) and the FY2025 annual result came in at $442.0 million, down 2.51% from the prior year.
- Depreciation & Amortization (CF) held at $112.9 million in Q1 2026 per QDEL's latest filing, from $112.5 million in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $246.3 million in Q1 2023 and troughed at $15.3 million in Q2 2022.
- A 5-year average of $110.5 million and a median of $112.9 million in 2026 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) soared 720.47% in 2022, then plunged 53.15% in 2023.
- Over 5 years, Depreciation & Amortization (CF) stood at $104.2 million in 2022, then advanced by 10.75% to $115.4 million in 2023, then retreated by 5.29% to $109.3 million in 2024, then climbed by 2.93% to $112.5 million in 2025, then grew by 0.36% to $112.9 million in 2026.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $112.9 million, $112.5 million, and $112.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 355.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 42.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 68.20 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 750.89 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 123.80 Mn |
| 10 | QuidelOrtho | 1.01 Bn | 885.73 Mn | - | 116.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | 116.70 Mn |
| Jun 28, 2026 | 116.70 Mn |
| Mar 29, 2026 | 112.90 Mn |
| Mar 29, 2026 | 112.90 Mn |
| Dec 28, 2025 | 112.50 Mn |
| Dec 28, 2025 | 112.50 Mn |
| Sep 28, 2025 | 112.10 Mn |
| Sep 28, 2025 | 112.10 Mn |
| Jun 29, 2025 | 110.30 Mn |
| Jun 29, 2025 | 110.30 Mn |
| Mar 30, 2025 | 107.10 Mn |
| Mar 30, 2025 | 107.10 Mn |
| Dec 29, 2024 | 109.30 Mn |
| Dec 29, 2024 | 109.30 Mn |
| Sep 29, 2024 | 113.10 Mn |
| Sep 29, 2024 | 113.10 Mn |
| Jun 30, 2024 | 116.10 Mn |
| Jun 30, 2024 | 116.10 Mn |
| Mar 31, 2024 | 114.90 Mn |
| Mar 31, 2024 | 114.90 Mn |